Publication Beamlines Strategic Pillar
C. Baribeau, M. Sigrist (2025). Magnetic measurement of a decommissioned insertion device at the Canadian Light Source. IPAC 16, 1843-1846. 10.18429/JACoW-IPAC2025-WEPB048. Materials
LI, Zexia; Zhang, Mingze; Wang, Lili; LI, Yizhan (2025). A Novel Type Collaboration: Global Big Science Facilities Co-utilization. . 10.51408/issi2025_121.
Peng, Hongwei; Bai, Penghui; Lu, Yuan; Zhu, Ning; Yang, Chen et al. (2025). The influence of scale inhibitor SAS/AA/AMPS on CO2 corrosion behavior of N80 steel in simulated produced water. Patent Number: 10.2139/ssrn.5472438. Materials
S. Saadat, M. Boland, P. Kallakuri (2025). Multimethod signal processing for comprehensive tune coupling characterization at Canadian Light Source. IPAC 16, 2909-2912. 10.18429/JACoW-IPAC2025-THPM106. Materials
Denis Spasyuk (2025). XASDB - Design and Implementation of an Open-Access Spectral Database. SK, Canada: Canadian Light Source. https://arxiv.org/abs/2509.13566. Materials
(2024). Exit Window for Electron Beam in Isotope Production. Patent Number: IL268283B2.
(2023). CORE/CASING ENGINEERING WITH GAPS (CSVE) OF CATALYST FOR ELECTROCHEMICAL CO2 REDUCTION. Patent Number: PT3791010T.
(2024). Antibodies that bind to a complex containing TNF from the TNF superfamily and a small molecule that is its modulator. Patent Number: IL256099B2.
(2025). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES BINDING BCMA AND CD3 AND THEIR USES. Patent Number: FR23C1012I2.
(2023). Antibodies to tigit. Patent Number: IL298111A.
(2023). ANTI-BCMA ANTIBODIES, BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND BCMA AND CD3, AND USES THEREOF. Patent Number: CY2023007I2.
(2023). teclistamab. Patent Number: NL301219I2.
(2023). ANTI-BCMA ANTIBODIES, BCMA AND CD3-BINDING BISPECIFIC ANTIGEN-BINDING MOLECULES AND USES THEREOF. Patent Number: FR23C1011I1.
(2023). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL257468B2.
(2025). Anti-bcma antibodies, bispecific antigen binding molecules that bind bcma and cd3, and uses thereof. Patent Number: IL320478A.